Perelman School of Medicine

Microscopic view of human respiratory epithelial cells infected with SARS-CoV-2.

New antiviral drug combination is highly effective against SARS-CoV-2

A Penn Medicine study finds that combining remdesivir or molnupiravir with the experimental drug brequinar blocked the replication of the virus that causes COVID-19 in lung cells.

Silhouette of a person sitting against a wall on the side of the image, legs pulled up close to her chest.

Why are alcohol- and drug-related deaths rising in the U.S. and not elsewhere?

With insights from anthropology and neuroscience, Penn researchers Michael Platt and Peter Sterling find that, in comparison, 16 other wealthy nations offer communal assistance at every life stage, support that protects individuals and families long term.

Two people stand closely together, smiling

Decade-long remission after CAR T cell therapy

Two patients represent longest-known CAR T cell response to date, providing insight into treatment effect and outcomes.

Parent at home with newborn in their arms.

Early discharge of healthy newborns during the pandemic

In a new study, Sara Handley and colleagues find that a shorter stay did not increase infant readmissions in the first week, suggesting that earlier discharge can be done safely.

Researchers Sara Cherry, Susan Davidson, Douglas Durian, Kathleen Hall Jamieson, Katalin Kariko, I. Joseph Kroll, Mingyao Li, Hongjun Song, Duncan Watts, and E. John Wherry

Ten from Penn elected 2021 AAAS Fellows

Ten scholars representing five schools across the University of Pennsylvania have been named to the 2021 class of American Association for the Advancement of Science Fellows, recognized for their “scientifically and socially distinguished achievements.”

After the shutdown, what comes next for the former Philadelphia Energy Solutions refinery?

Creating a greener, more equitable future at the site means understanding its complex history, its long-running public health impacts, and working in partnership with communities.

Microscopic view of a macrophage devouring a cancer cell.

First-in-human trial with CAR macrophages shows promise targeting solid tumors

A new Penn study demonstrates that engineered macrophages, which can be targeted to tumors, may be a possible new immune-based treatment of some cancers.

A patient having a telemedicine appointment with a doctor via a desktop computer screen.

Racial disparity in follow-up appointments disappears with telemedicine

An inequity in the rate of Black patients making it to their primary care appointment after a hospitalization was eliminated after telemedicine became widely used amid the COVID-19 pandemic.

Patient with a face mask looking at a computer with a medical professional.

Busting myths about the Asian American ‘model minority’

Two new studies highlight the problem with aggregating diverse groups of people into a single category of “Asian American” when applied to cardiovascular disease and cancer diagnosis and outcomes.

Microscopic view of nanomedicine particles attacked by immune system proteins.

A new method to increase effectiveness of nanomedicines

Penn Medicine researchers have developed a new technique that uses complement inhibitor Factor I to prevent proteins from attacking treatment-carrying nanoparticles so they can better reach targets within the body.

Filters